HRP20161635T1 - Novi derivati monenzina za liječenje i prevenciju protozoalnih infekcija - Google Patents

Novi derivati monenzina za liječenje i prevenciju protozoalnih infekcija Download PDF

Info

Publication number
HRP20161635T1
HRP20161635T1 HRP20161635TT HRP20161635T HRP20161635T1 HR P20161635 T1 HRP20161635 T1 HR P20161635T1 HR P20161635T T HRP20161635T T HR P20161635TT HR P20161635 T HRP20161635 T HR P20161635T HR P20161635 T1 HRP20161635 T1 HR P20161635T1
Authority
HR
Croatia
Prior art keywords
compound
use according
prevention
animal
coccidiosis
Prior art date
Application number
HRP20161635TT
Other languages
English (en)
Inventor
Jean Delaveau
Emilie Vialle
Marc Lemaire
Stephane Pellet-Rostaing
Bruno Andrioletti
Original Assignee
Merial, Inc.
Université Claude Bernard Lyon 1
Centre National De La Recherche Scientifique (Cnrs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial, Inc., Université Claude Bernard Lyon 1, Centre National De La Recherche Scientifique (Cnrs) filed Critical Merial, Inc.
Publication of HRP20161635T1 publication Critical patent/HRP20161635T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Claims (15)

1. Spoj, naznačen time, da je odabran od sljedećih: [image] [image] ili njegova veterinarski ili farmaceutski prihvatljiva sol.
2. Veterinarski ili farmaceutski sastav, naznačen time, da obuhvaća paraziticidno djelotvornu količinu spoja prema zahtjevu 1, u kombinaciji s veterinarski ili farmaceutski prihvatljivim nosačem ili razrjeđivačem.
3. Spoj prema zahtjevu 1, naznačen time, da se upotrebljava kao lijek.
4. Spoj prema zahtjevu 1, naznačen time, da se upotrebljava u liječenju ili prevenciji kokcidioze kod životinje, pri čemu ta životinja je ptica.
5. Spoj za uporabu prema zahtjevu 4, naznačen time, da se spoj primjenjuje oralno preko vode za piće ili kao dodatak prehrambenim sastavima.
6. Spoj prema za uporabu prema bilo kojem od zahtjeva 3 do 5, naznačen time, da se spoj primjenjuje u količini od 0,1 do 10 mg/kg prema tjelesnoj masi životinje.
7. Spoj prema za uporabu prema bilo kojem od zahtjeva 3 do 6, naznačen time, da se spoj primjenjuje s učinkovitom količinom cjepiva koje je djelotvorno za zaštitu ptica protiv protozoalnih zaraza.
8. Spoj prema zahtjevu 1, naznačen time, da se upotrebljava za smanjivanje ili eliminaciju babesioze kod goveda.
9. Spoj prema zahtjevu 1, naznačen time, da se upotrebljava u smanjivanju, prevenciji ili eliminaciji protozoalnih zaraza kod ljudi ili kod životinja.
10. Spoj prema zahtjevu 1, naznačen time, da se upotrebljava u smanjivanju, prevenciji ili eliminaciji malarije kod ljudi.
11. Spoj prema zahtjevu 1, naznačen time, da se upotrebljava u liječenju kokcidioze kod goveda, pri čemu se spoj primjenjuje kada postoje klinički pokazatelji kokcidiozne infekcije.
12. Spoj za uporabu prema zahtjevu 11, naznačen time, da se spoj primjenjuje u količini koja povećava dobitak na masi ugojenog goveda.
13. Spoj za uporabu prema zahtjevu 11 ili 12, naznačen time, da kokcidioza rezultira iz infekcije sa sljedećima: Eimeria bovis, E. aubemensis, ili Eimeria zuemii.
14. Spoj za uporabu prema bilo kojem od zahtjeva 11 do 13, naznačen time, da se navedeni spoj također upotrebljava za smanjivanje proljeva ili odbacivanja Eimeria oocyte kod navedene životinje.
15. Spoj, naznačen time, da ima sljedeću formulu (7): [image] koji se upotrebljava za suzbijanje endoparazita iz roda Eimeria spp.
HRP20161635TT 2010-11-16 2016-12-05 Novi derivati monenzina za liječenje i prevenciju protozoalnih infekcija HRP20161635T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41423410P 2010-11-16 2010-11-16
EP11791699.9A EP2640728B1 (en) 2010-11-16 2011-11-16 Novel monensin derivatives for the treatment and prevention of protozoal infections
PCT/US2011/060913 WO2012068202A1 (en) 2010-11-16 2011-11-16 Novel monensin derivatives for the treatment and prevention of protozoal infections

Publications (1)

Publication Number Publication Date
HRP20161635T1 true HRP20161635T1 (hr) 2017-02-24

Family

ID=45099195

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20161635TT HRP20161635T1 (hr) 2010-11-16 2016-12-05 Novi derivati monenzina za liječenje i prevenciju protozoalnih infekcija

Country Status (12)

Country Link
US (1) US8822528B2 (hr)
EP (1) EP2640728B1 (hr)
AU (1) AU2011328948B2 (hr)
CA (1) CA2818563C (hr)
DK (1) DK2640728T3 (hr)
HR (1) HRP20161635T1 (hr)
HU (1) HUE031125T2 (hr)
LT (1) LT2640728T (hr)
MX (1) MX2013005414A (hr)
NZ (1) NZ610547A (hr)
SI (1) SI2640728T1 (hr)
WO (1) WO2012068202A1 (hr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015025159A2 (pt) * 2013-04-04 2017-07-18 Harvard College macrolídeos e métodos de sua preparação e uso
CN110078749B (zh) * 2019-06-04 2021-01-01 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 3a,3a′-双呋喃[2,3-b]吲哚啉类化合物、制备方法、药物组合物及应用
RU2750707C1 (ru) * 2020-07-22 2021-07-01 Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) Способ профилактики эймериоза кур

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL160809C (nl) 1970-05-15 1979-12-17 Duphar Int Res Werkwijze ter bereiding van benzoylureumverbindingen, alsmede werkwijze ter bereiding van insekticide prepara- ten op basis van benzoylureumverbindingen.
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
JPS4914624A (hr) 1972-06-08 1974-02-08
US3818047A (en) 1972-08-07 1974-06-18 C Henrick Substituted pyrones
US3832358A (en) 1973-01-15 1974-08-27 Lilly Co Eli Deshydroxymethyl derivatives of monensin
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
CH604517A5 (hr) 1976-08-19 1978-09-15 Ciba Geigy Ag
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4134973A (en) 1977-04-11 1979-01-16 Merck & Co., Inc. Carbohydrate derivatives of milbemycin and processes therefor
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4144352A (en) 1977-12-19 1979-03-13 Merck & Co., Inc. Milbemycin compounds as anthelmintic agents
US4203976A (en) 1978-08-02 1980-05-20 Merck & Co., Inc. Sugar derivatives of C-076 compounds
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
JPS57139012A (en) 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
US4427663A (en) 1982-03-16 1984-01-24 Merck & Co., Inc. 4"-Keto-and 4"-amino-4"-deoxy avermectin compounds and substituted amino derivatives thereof
DE3235931A1 (de) 1982-09-29 1984-03-29 Bayer Ag, 5090 Leverkusen Koeder zur bekaempfung von ungeziefer
JPS59199673A (ja) 1983-04-25 1984-11-12 Sumitomo Chem Co Ltd 含窒素複素環化合物、その製造法およびそれを有効成分とする有害生物防除剤
DE3580444D1 (en) 1984-10-18 1990-12-13 Ciba Geigy Ag Benzoylphenylharnstoffe.
EP0192060B1 (de) 1985-02-04 1991-09-18 Nihon Bayer Agrochem K.K. Heterocyclische Verbindungen
EP0237482A1 (de) 1986-03-06 1987-09-16 Ciba-Geigy Ag C(29)-Carbonyloxi-milbemycin-Derivate zur Bekämpfung von tier- und pflanzenparasitären Schädlingen
RU2024527C1 (ru) 1986-03-25 1994-12-15 Санкио Компани Лимитед Способ получения макролидных соединений
DE3778768D1 (de) 1986-07-02 1992-06-11 Ciba Geigy Ag Pestizide.
FR2605221B1 (fr) * 1986-10-20 1989-09-01 Sanofi Sa Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine
US4855317A (en) 1987-03-06 1989-08-08 Ciba-Geigy Corporation Insecticides and parasiticides
US4871719A (en) 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US4874749A (en) 1987-07-31 1989-10-17 Merck & Co., Inc. 4"-Deoxy-4-N-methylamino avermectin Bla/Blb
EP0319142B1 (en) 1987-11-03 1994-04-06 Beecham Group Plc Intermediates for the preparation of anthelmintic macrolide antibiotics
NZ232422A (en) 1989-02-16 1992-11-25 Merck & Co Inc 13-ketal milbemycin derivatives and parasiticides
IE904606A1 (en) 1989-12-21 1991-07-03 Beecham Group Plc Novel products
WO1992022555A1 (en) 1991-06-17 1992-12-23 Beecham Group Plc Paraherquamide derivatives, precursor thereof, processes for their preparation, microorganism used and their use as antiparasitic agents
US5345377A (en) 1992-10-30 1994-09-06 Electric Power Research Institute, Inc. Harmonic controller for an active power line conditioner
GB9300883D0 (en) 1993-01-18 1993-03-10 Pfizer Ltd Antiparasitic agents
US5399582A (en) 1993-11-01 1995-03-21 Merck & Co., Inc. Antiparasitic agents
AUPM969994A0 (en) 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
JPH08231410A (ja) 1995-02-23 1996-09-10 Takasago Internatl Corp コクシジウム症軽減剤及びそれを含有する飼料
US6221894B1 (en) 1995-03-20 2001-04-24 Merck & Co., Inc. Nodulisporic acid derivatives
US5962499A (en) 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
MY113806A (en) 1995-07-21 2002-05-31 Upjohn Co Antiparasitic marcfortines and paraherquamides
FR2739255B1 (fr) 1995-09-29 1998-09-04 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
US5885607A (en) 1996-03-29 1999-03-23 Rhone Merieux N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs
IE80657B1 (en) 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
US6010710A (en) 1996-03-29 2000-01-04 Merial Direct pour-on skin solution for antiparasitic use in cattle and sheep
FR2752525B1 (fr) 1996-08-20 2000-05-05 Rhone Merieux Procede de lutte contre les myiases des cheptels bovins et ovins et compositions pour la mise en oeuvre de ce procede
US6426333B1 (en) 1996-09-19 2002-07-30 Merial Spot-on formulations for combating parasites
FR2753377B1 (fr) 1996-09-19 1999-09-24 Rhone Merieux Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6998131B2 (en) 1996-09-19 2006-02-14 Merial Limited Spot-on formulations for combating parasites
US6207647B1 (en) 1997-07-18 2001-03-27 Smithkline Beecham Corporation RatA
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
PE20011289A1 (es) 2000-04-07 2001-12-21 Upjohn Co Composiciones antihelminticas que comprenden lactonas macrociclicas y espirodioxepinoindoles
US6399786B1 (en) 2000-07-14 2002-06-04 Merck & Co., Inc. Nonacyclic nodulisporic acid derivatives
US7001889B2 (en) 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
TW200409760A (en) 2002-09-11 2004-06-16 Novartis Ag Organic compounds
CN101686962B (zh) 2007-06-29 2012-05-23 辉瑞大药厂 驱虫药联合用药
EP2070522A1 (en) 2007-12-11 2009-06-17 Universite Pierre Et Marie Curie Paris Vi Compounds for preventing and treating plasmodium infections.

Also Published As

Publication number Publication date
AU2011328948B2 (en) 2016-08-04
CA2818563A1 (en) 2012-05-24
NZ610547A (en) 2015-07-31
EP2640728A1 (en) 2013-09-25
DK2640728T3 (en) 2016-11-28
HUE031125T2 (en) 2017-07-28
LT2640728T (lt) 2017-03-27
US20120128722A1 (en) 2012-05-24
CA2818563C (en) 2019-11-12
MX2013005414A (es) 2013-08-29
AU2011328948A1 (en) 2013-06-06
WO2012068202A1 (en) 2012-05-24
US8822528B2 (en) 2014-09-02
EP2640728B1 (en) 2016-09-07
SI2640728T1 (sl) 2017-03-31

Similar Documents

Publication Publication Date Title
HRP20210038T1 (hr) Pirolopirimidini za uporabu u infekciji virusom gripe
HRP20211278T1 (hr) Supstituirani derivati indolina kao inhibitori replikacije denga virusa
HRP20151000T1 (hr) Antivirusni spojevi
HRP20211223T1 (hr) Heterociklički indoli za upotrebu kod infekcije virusom influence
HRP20210942T1 (hr) Supstituirani derivati indolina kao inhibitori replikacije denga virusa
HRP20201023T1 (hr) Dioksilan analozi uridina za liječenje raka
SV2010003582A (es) Derivados de aminobenzamida como agentes utiles para el control de parasitos de animales
HRP20191523T1 (hr) Paraziticidne kombinacije spirocikličkog izoksazolina
HRP20161635T1 (hr) Novi derivati monenzina za liječenje i prevenciju protozoalnih infekcija
HRP20202051T1 (hr) Aril supstituirani pirimidini za uporabu kod infekcije virusom influence
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
MX2018000285A (es) Composicion para desobstruir la nariz congestionada que tiene actividad antiviral.
HRP20130065T1 (hr) Cjepivo protiv salmonele za perad
BR112018010107A2 (pt) composição farmacêutica para o tratamento ou prevenção de nash
HRP20210010T1 (hr) Injekcijske farmaceutske formulacije lefamulina
HRP20220683T1 (hr) Liječenje parkinsonove bolesti
HRP20180428T1 (hr) Antibakterijski derivati tilozina i postupci njihovog dobivanja
RU2015127023A (ru) Лечение кокцидиоза внутримышечными композициями триазина
MX2018011974A (es) Composicion para controlar microsporidia en peces y metodo para controlar microsporidia en peces utilizando la misma.
JP2018035071A (ja) 抗トキソプラズマ剤
JP2017532369A5 (hr)
HRP20201508T1 (hr) Spojevi s antioksidativnim djelovanjem protiv slobodnih radikala i protupapalnom aktivnosti te odgovarajući farmaceutski pripravci za njegu kože
RU2016137926A (ru) Композиции грапипранта и способы их применения
SI2999707T1 (en) Tylosin derivatives and their preparation process
HRP20211726T1 (hr) Derivati imidazopiridina i njihova uporaba kao lijeka